[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-337872-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-337872-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","prognostic-significance-and-value-of-further-classification-of-lymphovascular-invasion-in-invasive-breast-cancer-a-retrospective-observational-study","Prognostic significance and value of further classification of lymphovascular invasion in invasive breast cancer - a retrospective observational study","","The study investigates whether lymphovascular invasion (LVI) in invasive breast cancer predicts clinical outcomes and whether additional classification using specific vascular endothelial markers improves prognostic value. Data from 2124 hospitalized patients (2012–2020) were analyzed for links between LVI and clinicopathological features, and for associations with overall survival and disease-free survival. Immunohistochemical staining with D2-40 and CD34 classified LVI and assessed its relationship with progression. Results show LVI correlates with T stage, N stage, and nerve invasion, and independently predicts worse OS and DFS.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/prognostic-significance-and-value-of-further-classification-of-lymphovascular-invasion-in-invasive-breast-cancer-a-retrospective-observational-study/337872/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/prognostic-significance-and-value-of-further-classification-of-lymphovascular-invasion-in-invasive-breast-cancer-a-retrospective-observational-study/337872.png","ImageObject",300,407,{"name":42,"@type":43},"Violet","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-26","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",12,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What question does the study address about lymphovascular invasion (LVI)?","Question",{"text":63,"@type":64},"It evaluates the prognostic significance of LVI in invasive breast cancer and the added value of further classifying LVI using specific vascular endothelial markers.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were patients and outcomes analyzed in this study?",{"text":68,"@type":64},"The study included 2124 patients treated at a single hospital from 2012 to 2020, analyzing relationships between LVI and clinicopathological characteristics and correlating LVI categories with overall survival and disease-free survival.",{"name":70,"@type":61,"acceptedAnswer":71},"Which immunohistochemical markers were used to further classify LVI, and what was found?",{"text":72,"@type":64},"Lymphovascular invasion was classified using D2-40 and CD34 immunohistochemical staining. Positive D2-40 staining of LVI was linked to N stage and localized recurrence.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},337872,1790093663,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},4398048950312,"https://ap-avatar.wpscdn.com/avatar/400002538284de19e3c?_k=1778320343897328908","Breast Cancer Research and Treatment (2024) 206:397–410  \n[https://doi.org/10.1007/s10549-024-07318-6](https://doi.org/10.1007/s10549-024-07318-6)  \nPrognostic significance and value of further classification of lymphovascular invasion in invasive breast cancer: a retrospective observational study  \nYuyang Zhang1 · Huali Wang2 · Huahui Zhao1 · Xueming He1 · Ya Wang1 · Hongjiang Wang1  \nReceived: 18 February 2024 / Accepted: 28 March 2024 / Published online: 21 May 2024 © The Author(s) 2024  \nAbstract  \nPurpose To investigate the prognostic significance of lymphovascular invasion in invasive breast cancer and the value of using specific vascular endothelial markers to further classify lymphovascular invasion.  \nMethods We collected 2124 patients with invasive breast cancer who were hospitalized at the First Hospital of Dalian Medical University from 2012 to 2020. Statistical methods were used to investigate the relationship between lymphovascular invasion and clinicopathological characteristics of breast cancer, and the correlation between lymphovascular invasion on overall survival (OS) and disease-free survival (DFS) of various categories of breast cancers. Immunohistochemical staining of breast cancer samples containing lymphovascular invasion using specific vascular endothelial markers D2-40 and CD34 was used to classify lymphovascular invasion and to investigate the relationship between lymphovascular invasion and breast cancer progression.  \nResults There was a high correlation between lymphovascular invasion and T stage, N stage and nerve invasion. Survival analyses showed that patients with lymphovascular invasion, especially luminal B, triple-negative, and Her-2 overexpression breast cancer patients, had poorer OS and DFS prognosis, and that lymphovascular invasion was an independent prognostic factor affecting OS and DFS in breast cancer. The immunohistochemical staining results showed that positive D2-40 staining of lymphovascular invasion was linked to the N stage and localized recurrence of breast cancer.  \nConclusion Lymphovascular invasion is associated with aggressive clinicopathological features and is an independent poor prognostic factor in invasive breast cancer. Breast cancer localized recurrence rate and lymph node metastases are influenced by lymphatic vessel invasion. Immunohistochemical techniques should be added to the routine diagnosis of lymphovascular invasion.  \nKeywords Breast cancer · Lymphovascular invasion · Prognosis · Specific vascular endothelial marker  \nYuyang Zhang and Huali Wang are co-first authors, and contributed equally to this work.  \n* Ya Wang [13478616227@163.com](13478616227@163.com)  \n* Hongjiang Wang [wanghj2001@outlook.com](wanghj2001@outlook.com)  \nYuyang Zhang  \n[zyylpd@sina.com](zyylpd@sina.com)  \nHuali Wang  \n[yaya1167@163.com](yaya1167@163.com)  \n1 Department of Breast Surgery, The First Affiliated Hospital of Dalian Medical University, No. 193, Union Road, Shahekou District, Dalian, Liaoning, China  \n2 Department of Pathology, The First Affiliated Hospital of Dalian Medical University, Dalian, China  \nAbbreviations  \nLVI Lymphovascular invasion H&E Hematoxylin–eosin IHC Immunohistochemistry  \nOS Overall survival  \nDFS Disease-free survival  \nAJCC American Joint Committee on Cancer OR Odds ratio  \nHR Hazard ratio  \nER Estrogen receptor PR Progesterone receptor  \nHER2 Human epidermal growth factor receptor 2 LEC Lymphatic endothelial cells  \nBVI Blood vessel invasion  \nIntroduction  \nBased on the worldwide cancer data released by CA Cancer J Clin 2021[1], breast cancer is the most prevalent malignant tumor worldwide at the moment. According to the data, breast cancer accounts for 15.5 percent of cancer mortality in women, which is higher than other types of cancers such as lung, colorectal, and cervical cancer. The diagnosis and treatment of breast cancer have evolved as we approach the era of precision therapy. An exact disease risk assessment is essential to creating a t","cbCaitqwR805tBVD","https://ap.wps.com/l/cbCaitqwR805tBVD","pdf",4418046,14,"English","# Abstract\n## Purpose\n## Methods\n## Results\n## Conclusion\n# Keywords\n# Introduction","[{\"question\":\"What question does the study address about lymphovascular invasion (LVI)?\",\"answer\":\"It evaluates the prognostic significance of LVI in invasive breast cancer and the added value of further classifying LVI using specific vascular endothelial markers.\"},{\"question\":\"How were patients and outcomes analyzed in this study?\",\"answer\":\"The study included 2124 patients treated at a single hospital from 2012 to 2020, analyzing relationships between LVI and clinicopathological characteristics and correlating LVI categories with overall survival and disease-free survival.\"},{\"question\":\"Which immunohistochemical markers were used to further classify LVI, and what was found?\",\"answer\":\"Lymphovascular invasion was classified using D2-40 and CD34 immunohistochemical staining. Positive D2-40 staining of LVI was linked to N stage and localized recurrence.\"}]","Prognostic significance and value of further classification of lymphovascular invasion in invasive breast cancer - a retrospective observational study | PDF",1790021003,35,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7fa6cecc4dcd85d728661c7728cf741b.webp",983,1305,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/04619e9ce202bf0b373b567cce952283.webp",982,1304,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b16459bd68db1082988b6ef95a003781.webp",981,1303,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/082d6379e6b4f02dc08b006cbb839218.webp",980,1301]